TW200504199A - Method of preventing lipids constituting lipid membrane from degradation and use thereof - Google Patents
Method of preventing lipids constituting lipid membrane from degradation and use thereofInfo
- Publication number
- TW200504199A TW200504199A TW093104968A TW93104968A TW200504199A TW 200504199 A TW200504199 A TW 200504199A TW 093104968 A TW093104968 A TW 093104968A TW 93104968 A TW93104968 A TW 93104968A TW 200504199 A TW200504199 A TW 200504199A
- Authority
- TW
- Taiwan
- Prior art keywords
- lipid membrane
- degradation
- lipids constituting
- alpha
- trehalose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/779—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Birds (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Fodder In General (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
It is intended to provide a method of preventing lipids constituting a lipid membrane from degradation, a composition produced b using this method, and a degradation inhibitor for lipids constituting a lipid membrane. These objects are achieved by providing a method of preventing lipids constituting a lipid membrane from degradation which comprises adding alpha,alpha-trehalose and/or alpha,beta-trehalose to the lipid membrane or a material or an intermediate product containing the lipid membrane; a composition produced by using this method; and a degradation inhibitor for lipids constituting a lipid membrane which contains alph, alpha-trehalose and/or alpha,beta-trehalose as the active ingredient.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003051925 | 2003-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200504199A true TW200504199A (en) | 2005-02-01 |
Family
ID=32923383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093104968A TW200504199A (en) | 2003-02-27 | 2004-02-26 | Method of preventing lipids constituting lipid membrane from degradation and use thereof |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2004076602A1 (en) |
TW (1) | TW200504199A (en) |
WO (1) | WO2004076602A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006117534A (en) * | 2004-10-19 | 2006-05-11 | Kose Corp | Emulsified cosmetic |
JP4212561B2 (en) * | 2005-01-25 | 2009-01-21 | くじらハウス株式会社 | Antibacterial paper, non-woven or textile products |
JP5177338B2 (en) * | 2005-02-18 | 2013-04-03 | 株式会社林原 | L-ascorbic acid glucoside-containing liposome solution |
JP2006316053A (en) * | 2005-04-13 | 2006-11-24 | Hayashibara Biochem Lab Inc | Cytotoxic inhibitors and their uses |
MY142987A (en) | 2005-06-08 | 2011-02-14 | Hayashibara Biochem Lab | Solution for tissue adhesion prevention and method for tissue adhesion prevention |
JP5635226B2 (en) * | 2006-01-24 | 2014-12-03 | 株式会社林原 | Hair papilla cell growth promoter |
JP4960004B2 (en) * | 2006-04-10 | 2012-06-27 | ポーラ化成工業株式会社 | Ubidecalenone-containing cosmetic in vesicle dispersion dosage form |
JPWO2008026310A1 (en) * | 2006-08-29 | 2010-01-14 | 株式会社セレックス | Trehalose-containing oral mucosa protective agent |
WO2008142853A1 (en) * | 2007-05-18 | 2008-11-27 | En Otsuka Pharmaceutical Co., Ltd. | Food for people having chewing and swallowing difficulties and method of producing the same |
JP2009284863A (en) * | 2008-05-30 | 2009-12-10 | Otsuka Pharmaceut Factory Inc | Method for assessing food storage method |
JP2011153089A (en) * | 2010-01-27 | 2011-08-11 | Lion Corp | Gel-like finger disinfectant |
JP2019182803A (en) * | 2018-04-13 | 2019-10-24 | 花王株式会社 | Muscle fatigue recovery agent |
JP7246637B2 (en) * | 2019-06-12 | 2023-03-28 | 地方独立行政法人北海道立総合研究機構 | Frozen sea urchin and method for producing the same |
JP7396585B2 (en) * | 2019-10-31 | 2023-12-12 | 晴義 山田 | Composition for suppressing TSLP gene expression, suppressing IL-33 gene expression, or promoting filaggrin production |
JP2023525662A (en) * | 2020-04-17 | 2023-06-19 | 株式会社ネクスト21 | Medicines and nasal sprays containing trehalose or derivatives of trehalose |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3253131B2 (en) * | 1992-07-24 | 2002-02-04 | 洋巳 和田 | Transplant organ solution |
JP3963491B2 (en) * | 1994-03-01 | 2007-08-22 | 株式会社林原生物化学研究所 | Crystalline maltosyl glucoside, its production method and use |
JPH11263795A (en) * | 1997-03-04 | 1999-09-28 | Hayashibara Biochem Lab Inc | Active oxygen deletion ability deterioration inhibitor |
JP4663834B2 (en) * | 1998-09-03 | 2011-04-06 | 株式会社林原生物化学研究所 | Method for inhibiting formation of volatile aldehydes and / or decomposition of fatty acids and use thereof |
US7192746B2 (en) * | 2000-05-22 | 2007-03-20 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | α-Isomaltosyltransferase, process for producing the same and use thereof |
US6653062B1 (en) * | 2000-07-26 | 2003-11-25 | Wisconsin Alumni Research Foundation | Preservation and storage medium for biological materials |
-
2004
- 2004-02-25 JP JP2005502907A patent/JPWO2004076602A1/en active Pending
- 2004-02-25 WO PCT/JP2004/002206 patent/WO2004076602A1/en active Application Filing
- 2004-02-26 TW TW093104968A patent/TW200504199A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004076602A1 (en) | 2004-09-10 |
JPWO2004076602A1 (en) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200504199A (en) | Method of preventing lipids constituting lipid membrane from degradation and use thereof | |
MX2008007307A (en) | Modified active-ingredient-containing pellets/capsules. | |
TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
UA89220C2 (en) | METHOD OF TREATMENT OF HIV / AIDS BY INJURY WITHOUT FOOD OR UNDER CONDITIONS OF STORAGE OF SOLID PHARMACEUTICAL DOSAGE INHIBITOR INHIBITOR | |
MX346822B (en) | Prodrugs of 2,4-pyrimidinediamine compounds and their uses. | |
EA015464B9 (en) | Herbicidal compositions having improved effect | |
MXPA06000407A (en) | Cci-779 isomer c. | |
WO2005067627A3 (en) | Cosmetic composition and method for retarding hair growth | |
TW200735773A (en) | Insecticidal compositions with improved activity | |
HK1129581A1 (en) | ||
TW200510375A (en) | New compounds | |
DE502004008588D1 (en) | AGROCHEMICAL FORMULATIONS | |
UA90439C2 (en) | Composition and method for regulating growth of plant or propagation material thereof | |
WO2005000248A3 (en) | Compositions and methods for skin conditioning | |
AU2003293555A1 (en) | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
PA8577201A1 (en) | 3-PHENYL-PROPIONAMIDE, 3-PHENYL-ACRYLAMID AND DERIVATIVES 3-PHENYL-PROPINAMID AS MAO-B INHIBITORS | |
AU2003239793A1 (en) | Alicyclic esters having a musky smell | |
MX2007013327A (en) | Extended release formulations. | |
WO2005065639A3 (en) | Novel pharmaceutical compositions | |
UY28247A1 (en) | BENZOPIRAN COMPOUNDS FOR USE IN THE TREATMENT AND PREVENTION OF AFFECTIONS RELATED TO INFLAMMATION. | |
ATE365036T1 (en) | CREATINESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS | |
CR8135A (en) | TRIAZOLOPIRIMIDINS | |
NO20073046L (en) | Selected benzofuran derivatives | |
AU2003280275A1 (en) | Aliphatic compounds as fragrants with musk characteristics | |
WO2000059448A3 (en) | Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |